Business Description
Physiomics PLC
ISIN : GB00BDR6W943
Description
Physiomics PLC is a United Kingdom-based firm providing services to pharmaceutical companies through outsourced systems and computational biology. The company is mainly engaged in the development of models to streamline the drug discovery and development process. It focuses to transform oncology drug development. The company operates in the UK, European Union Switzerland and USA.
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.85 | |||||
Interest Coverage | No Debt | |||||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | -9.01 | |||||
Beneish M-Score | -3.95 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -18.3 | |||||
3-Year EBITDA Growth Rate | -44.2 | |||||
3-Year EPS without NRI Growth Rate | -71 | |||||
3-Year FCF Growth Rate | -14.5 | |||||
3-Year Book Growth Rate | -29.1 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 58.09 | |||||
9-Day RSI | 52.68 | |||||
14-Day RSI | 48.6 | |||||
6-1 Month Momentum % | -53.57 | |||||
12-1 Month Momentum % | -35 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 6.47 | |||||
Quick Ratio | 6.47 | |||||
Cash Ratio | 3.33 | |||||
Days Sales Outstanding | 164.91 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -0.6 | |||||
Shareholder Yield % | -22.95 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | -82.62 | |||||
Net Margin % | -71.25 | |||||
FCF Margin % | -68.34 | |||||
ROE % | -68.82 | |||||
ROA % | -55.72 | |||||
ROIC % | -163.14 | |||||
ROC (Joel Greenblatt) % | -294.37 | |||||
ROCE % | -79.85 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 1.21 | |||||
PB Ratio | 1.45 | |||||
Price-to-Tangible-Book | 0.7 | |||||
EV-to-EBIT | -2.05 | |||||
EV-to-Forward-EBIT | -1.65 | |||||
EV-to-EBITDA | -2.09 | |||||
EV-to-Revenue | 1.69 | |||||
EV-to-Forward-Revenue | 1.48 | |||||
EV-to-FCF | -2.47 | |||||
Price-to-Median-PS-Value | 0.23 | |||||
Price-to-Net-Current-Asset-Value | 0.7 | |||||
Earnings Yield (Greenblatt) % | -48.78 | |||||
FCF Yield % | -29.4 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Physiomics PLC Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 0.736 | ||
EPS (TTM) (€) | -0.005 | ||
Beta | 1.93 | ||
Volatility % | 85.06 | ||
14-Day RSI | 48.6 | ||
14-Day ATR (€) | 0.000338 | ||
20-Day SMA (€) | 0.006775 | ||
12-1 Month Momentum % | -35 | ||
52-Week Range (€) | 0.006 - 0.04 | ||
Shares Outstanding (Mil) | 203.21 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Physiomics PLC Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Physiomics PLC Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Physiomics PLC Frequently Asked Questions
What is Physiomics PLC(STU:RVW1)'s stock price today?
The current price of STU:RVW1 is €0.01. The 52 week high of STU:RVW1 is €0.04 and 52 week low is €0.01.
When is next earnings date of Physiomics PLC(STU:RVW1)?
The next earnings date of Physiomics PLC(STU:RVW1) is 2024-09-27 Est..
Does Physiomics PLC(STU:RVW1) pay dividends? If so, how much?
Physiomics PLC(STU:RVW1) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |